Oncolytics Biotech Highlights Pelareorep Efficacy in Metastatic Colorectal Cancer

Oncolytics Biotech announced positive clinical and translational data for pelareorep in metastatic colorectal cancer (mCRC). In the REO 022 trial, pe...
Home/KnloSights/Clinical Trial Updates/Oncolytics Biotech Highlights Pelareorep Efficacy in Metastatic Colorectal Cancer